20377 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Non condensed pyridines; Hydrogenated derivatives thereof; Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
SUBSTITUTED 3-FLUOROBENZENEPROPANOATE COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF
#2THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING MOVEMENT DISORDERS
#3STABLE PITOLISANT LIQUID FORMULATIONS AND METHOD OF ITS USE
#42,4 DNP and Prodrugs Thereof for Treatment of Cancer
#5GEL-CHEWABLE DOSAGE FORM
#6R-TRIHEXYPHENIDYL FOR TREATMENT OF MOVEMENT DISORDERS
#7SQUARAMIDE DERIVATIVES AS CB1 ALLOSTERIC MODULATORS
#8ENTERIC COATED PITOLISANT FORMULATIONS AND METHODS OF USE
#9R-TRIHEXYPHENIDYL FOR TREATMENT OF MOVEMENT DISORDERS
#10CHEMICAL COMPOUNDS AND USES THEREOF
#112,6-DIBENZYLIDENECYCLOHEXANONE OXIME COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF
#12USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)-KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN
#13BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE
#14A PHARMACEUTICAL COMPOSITION OF PITOLISANT HYDROCHLORIDE AND THEIR PROCESS FOR THE PREPARATION
#15USE OF PRIDOPIDINE FOR THE TREATMENT OF ANXIETY AND DEPRESSION
#16COMPOSITIONS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES
#17PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#18METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS
#19NOVEL USE OF PITOLISANT FOR TREATING SEVERE FATIGUE
#20ORGANIC MOLECULES FOR TREATING MYELIN PATHOLOGIES
#21ENTERIC COATED PITOLISANT FORMULATIONS AND METHODS OF USE
#22POLYMORPH FORM OF PITOLISANT HYDROCHLORIDE
#23SMALL MOLECULES TARGETTING EIF3E TO INHIBIT TUMOR GROWTH PROGRESSION, AND METASTASIS
#24NEW FORMULATIONS OF PITOLISANT AND METHODS OF USE
#25NEW FORMULATIONS OF PITOLISANT AND METHODS OF USE
#26TOPICAL OCULAR ADMINISTRATION OF AMBROXOL FOR OCULAR PAIN
#27Anticonvulsant Compounds
#28SOLID FORMS OF 1-{3-[3-(4-CHLOROPHENYL) PROPOXY] PROPYL} PIPERIDINE HYDROCHLORIDE AND PROCESS FOR THE PREPARATION THEREOF
#293CLPRO PROTEASE INHIBITOR
#30CATIONIC LIPID CONTAINING SIDE-CHAIN FUNCTIONAL GROUPS AND APPLICATION THEREOF
#31CATIONIC STEROID COMPOUNDS, METHOD OF OBTAINING THEREOF, FORMULATIONS COMPRISING THEREOF AND THEIR USES
#32METHOD OF TREATING SYMPTOMS OF PRADER-WILLI SYNDROME
#33DERIVATIVES OF THE PROTECTIN 10S,17S-DIHDA (PDX) AND USE THEREOF AS ANTIVIRAL, ANTI-INFLAMMATORY, AND ANTI-DIABETIC AGENTS
#34OXIMES AND THEIR USE IN TREATMENT OF GBA-RELATED DISEASES
#35Polymorph form of pitolisant hydrochloride
#36USE OF SOBETIROME AND PRODRUGS AND DERIVATIVES THEREOF FOR TREATING PITT-HOPKINS SYNDROME
#376-SUBSTITUTED NAPHTHALENE-1,3-DISULFONIC ACID DERIVATIVES AS MODULATORS OF THE EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (ENAMPT) FOR THE TREATMENT OF E.G. DIABETES
#383-SUBSTITUTED 1H-PYRROLO[2,3-B]PYRIDINE AS GRK5 MODULATORS
#39ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS
#40Pharmaceutical Mixture Comprising Amorphous Pitolisant
#41ARYLSULFONAMIDES AS OREXIN RECEPTOR AGONISTS
#42HIGH PENETRATION PRODRUG COMPOSITIONS OF RETINOIDS AND RETINOID-RELATED COMPOUNDS
#43AMINONAPHTHOQUINONE COMPOUNDS FOR TREATMENT AND/OR PREVENTION OF FIBROSIS DISEASES
#44Compositions having improved bioavailability of therapeutics
#45USE OF PRIDOPIDINE FOR THE TREATMENT OF ANXIETY AND DEPRESSION
#46USE OF FATTY ACID OXIDATION INHIBITORS AS ANTIMICROBIALS
#47METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#48Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms
#49ANTI-VERTIGO COMPOUND AND PHARMACEUTICAL COMPOSITIONS THEREOF
#50REPURPOSING FDA-APPROVED DRUGS AS A NOVEL CANCER THERAPEUTIC AVENUE THROUGH INHIBITION OF PRMT5
#51BRAIN HEALTH FORMULATION
#52Topical anesthetics
#53FORMULATIONS AND METHODS FOR TREATMENT OF FIBROMYALGIA AND RELATED MYOFASCIAL PAIN DISORDERS
#54COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD)
#55ANTIVIRAL COMPOSITION OBTAINED THROUGH DRUG REPOSITIONING
#56METHOD OF USING HUMAN SPHEROIDS FOR DRUG DISCOVERY
#57Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
#58Histone acetyltransferase activators and compositions and uses thereof
#59Aminothiolester compounds or pharmaceutically acceptable salts thereof, for use for the treatment of cancer
#60PROTEIN-PROTEIN INTERACTION STABILIZERS
#61COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
#62ENHANCEMENT OF CAMP SIGNALING AS A COMBINATION DRUG STRATEGY FOR THE TREATMENT OF PSYCHIATRIC AND NEUROLOGICAL DISORDERS IN WHICH DEPRESSIVE, ANHEDONIA, MOTIVATION-RELATED OR COGNITION-RELATED DYSFUNCTION EXISTS
#63DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic Diseases
#64COMPOUNDS AND METHODS FOR THE TREATMENT OF MICROBIAL INFECTIONS
#65METHODS FOR TREATING DISEASES BY TARGETING ONCOGENIC LIPIDS
#66Stilbene derivative and method for preparing same
#67Small Molecule Inhibitors of Viral Replication
#68METHOD FOR TREATMENT OF PANCREATITIS
#69Extended release compositions comprising trihexyphenidyl
#70ENDOCANNABINOID SYSTEM-TARGETING PRODRUGS AND THERAPEUTIC USES THEREOF
#71GEL-CHEWABLE DOSAGE FORM
#72SOTORASIB DOSING REGIMEN
#73Compositions Having Improved Bioavailability of Therapeutics
#74COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND CAPSID ASSEMBLY MODULATORS BEING SULFONAMIDE DERIVATIVES
#75THE SERPINB3 INHIBITOR PIPERIDINPROPIONIC ACID FOR TUMOR TREATMENT
#76Extended release compositions comprising trihexyphenidyl
#77Composition for Prevention, Amelioration, or Treatment of Cancer
#78MORPHINE-INDUCED RESPIRATORY DEPRESSION: BEHAVIORAL, PHRENIC AND BRAINSTEM RESPIRATORY NEURONAL EVIDENCE
#79INHIBITORS OF NCCA-ATP CHANNELS FOR THERAPY
#80MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION
#81PRESYNAPTIC GLUTAMATE RELEASE INHIBITORS FOR DECREASING NMDA ANTAGONIST SIDE EFFECTS IN ANESTHESIA
#82Biguanide compositions and methods of treating metabolic disorders
#83COMPOSITIONS AND METHODS FOR TREATING IDIOPATHIC PULMONARY FIBROSIS
#84R-KETAMINE AND DERIVATIVE THEREOF AS PROPHYLACTIC OR THERAPEUTIC AGENT FOR NEURODEVELOPMENTAL DISORDER
#85METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#86Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof
#872-BENZOYLAMINOBENZAMIDE DERIVATIVES AS BCL-3 INHIBITORS
#88Method for the treatment of pancreatitis
#89Compounds for treating myelin related disorders
#90MACROLIDE COMPOUNDS AND THEIR USE IN LIVER STAGE MALARIA AND RELATED DISEASE
#91Extended release compositions comprising trihexyphenidyl
#92Method and composition for preventing and treating viral infections
#93PROPHYLACTIC OR THERAPEUTIC AGENT FOR PROSTATE CANCER
#94Compositions and methods of use thereof for treatment of proteinopathies
#95High penetration prodrug compositions of retinoids and retinoids-related compounds
#96Platform drug delivery system utilizing crystal engineering and theanine dissolution
#97KDM1A inhibitors for the treatment of disease
#981-piperidinepropionic acid for treating a fibrosing disease
#99CGRP ANTAGONISTS AND CLOSTRIDIAL DERIVATIVES FOR THE TREATMENT OF CORTICAL SPREADING DEPRESSION ASSOCIATED DISORDERS
#100USE OF PRIDOPIDINE FOR THE TREATMENT OF ANXIETY AND DEPRESSION
#101Inhibitors of glucosylceramide degradation in the treatment of diseases of the motor units
#102Method of treating or preventing neurodegeneration
#103SULFAMOYLBENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION
#104SYNERGISTIC DRUG COMBINATIONS PREDICTED FROM GENOMIC FEATURES AND SINGLE-AGENT RESPONSE PROFILES
#105METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#106Extended release compositions comprising trihexyphenidyl
#107Extended release compositions comprising trihexyphenidyl
#108SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#109PHENYLALANINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCERS
#110Anticonvulsant compounds
#111Use of fatty acid oxidation inhibitors as antimicrobials
#112METHOD OF USING HUMAN SPHEROIDS FOR DRUG DISCOVERY
#113METHODS OF ADMINISTERING TOLPERISONE
#114USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)-KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN
#115Ligands of the mu, kappa, and delta opioid receptors
#116Histone acetyltransferase activators and compositions and uses thereof
#117FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF
#118ENGINEERED CELLS AND AGENT COMPOSITIONS FOR THERAPEUTIC AGENT DELIVERY AND TREATMENTS USING SAME
#119Compounds affecting pigment production and methods for treatment of bacterial diseases
#120Extended release compositions comprising trihexyphenidyl
#121SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#122Undecylenic acid-based nanocarriers for targeted drug delivery
#123FORMULATIONS AND METHODS FOR TREATMENT OF FIBROMYALGIA AND RELATED MYOFASCIAL PAIN DISORDERS
#124Adrenergic receptor modulating compounds and methods of using the same
#125BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE
#126INHIBITOR OF TRPM-4 ION CHANNEL FOR TREATING OR PREVENTING NEURODEGENERATION
#127FLT3 INHIBITORS FOR IMPROVING PAIN TREATMENTS BY OPIOIDS
#128Anticonvulsant compounds
#129Biguanide compositions and methods of treating metabolic disorders
#130COMPOUNDS AND COMPOSITIONS FOR EXTENDING LIFESPAN OF A SUBJECT
#131Compositions and methods for treating neurodegenerative diseases
#132KDM1A inhibitors for the treatment of disease
#133DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases
#134Compounds and methods for the treatment of microbial infections
#135Pyridinone compound and use thereof
#136Treating male senescence
#1372-benzoylaminobenzamide derivatives as Bcl-3 inhibitors
#138Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof
#139Purpose for Soothing Brain Disorders of Patients from Drug Detoxification Using Biperiden HCL
#140Polymer-Free Drug Eluting Vascular Stents
#141Method and composition for preventing and treating viral infections
#142SYNTHESIS OF RESORCYLIC ACID LACTONES USEFUL AS THERAPEUTIC AGENTS
#143MODULATION OF ISCHEMIC CELL BIOENERGETICS
#144SULFAMOYLBENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION
#145COMPOSITIONS AND METHODS FOR INCREASING REMYELINATION
#146CYCLIC AMINES
#147Compositions and methods of treating diabetic retinopathy
#148Stilbene derivative and method for preparing same
#149Stilbene derivative and method for preparing same
#150Use of Sigma-1 receptor agonist compounds
#151Sulfide alkyl compounds for HBV treatment
#152Compositions and Methods for Inhibiting Stem Cell Aging
#153Entacapone-related compounds to treat macular degeneration
#154FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF
#155BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE
#156K-RAS MUTATIONS AND ANTAGONISTS
#157Methods of Anesthetizing Nerve Tissue in the Trigeminal Nerve Pathway and Medical Uses Thereof
#158METHODS AND COMPOSITIONS FOR REMOVING, REDUCING, DISPERSING, DISRUPTING OR ERADICATING BIOFILMS AND DETERMINING THE NUMBER OF BACTERIAL POPULATION IN BIOFILM OR A CULTURE CONTAINING BACTERIAL AGGREGATE
#159Biguanide compositions and methods of treating metabolic disorders
#160Compounds and methods for the treatment of microbial infections
#161COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES
#162Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits
#163Heterocyclic compounds
#164COMPOSITIONS OF TOLPERISONE
#165AGENTS USEFUL FOR TREATING FRIEDREICH'S ATAXIA AND OTHER NEURODEGENERATIVE DISEASES
#166Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases
#167Hair-growth promoting composition and usage thereof
#168Combination comprising an aminothiolester compound or a pharmaceutically acceptable salt thereof and a compound able to increase the H2O2 level in cancer cells of a subject
#169AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER
#170EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
#171Non-hydrophobic compounds for use in treating metastasis and/or cartilage defect
#172EXTERNAL PREPARATION COMPRISING FATTY ACID SALT OR BENZOIC ACID SALT OF BASIC PHARMACOLOGICALLY ACTIVE COMPONENT, AND METHOD FOR PRODUCTION THEREOF
#173Farnesoid X receptor agonists and uses thereof
#174Compositions and methods for treating neurodegenerative diseases
#175Cyclic amines
#176METHODS FOR TREATING NEURAL CELL SWELLING
#177BIPERIDEN FOR TREATING CANCER
#178SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS
#179Method of treating Crohn's disease comprising a TLR2 antagonist
#180Method for producing dicarboxylic acid compound
#181METHODS OF TREATING DEVELOPMENTAL DISORDERS USING PIPRADROL
#182Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
#183Method for treating pain
#184Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
#185COMPOUNDS FOR TREATING DISORDERS ASSOCIATED WITH BK CHANNEL MODULATION
#186USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN
#187Method of inhibiting apolipoprotein-E expression while increasing expression of at least one of LDL-receptor protein or AbcA1 protein comprising administering a small compound
#188Pyridinone compound and use thereof
#189Histone acetyltransferase activators and compositions and uses thereof
#190OCT3 activity inhibitor containing imidazopyridine derivative as active component, and OCT3 detection agent
#191Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#192SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA
#193PHOTOACTIVATABLE CAGED TAMOXIFEN AND TAMOXIFEN DERIVATIVE MOLECULES AND METHODS OF USE THEREOF
#194Hepatitis B antiviral agents
#195KDM1A inhibitors for the treatment of disease
#196INHIBITORS OF NCCA-ATP CHANNELS FOR THERAPY
#197Pentadienoyl piperidine derivative and use thereof
#198SULFAMOYLBENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION
#199GLP-1 receptor modulators
#200Methods for treating central or peripheral nervous system damage
#201Sulfide alkyl compounds for HBV treatment
#202DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases
#203COMPOSITIONS OF TOLPERISONE
#204FLT3 receptor antagonists
#205Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, AIDs, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#206Novel Triarylethylene Compounds and Methods Using Same
#207Methods of treating developmental disorders using pipradrol
#208Biguanide compositions and methods of treating metabolic disorders
#209Compositions and methods of treating diabetic retinopathy
#210Compounds and methods for inhibiting production of trimethylamine
#211Methods for inhibiting conversion of choline to trimethylamine (TMA)
#212Diarylalkylamine REV-ERB antagonists and their use as medicaments
#213Cyclic amines
#214Organoselenium compounds, method for producing same, and pharmaceutical uses thereof in particular as antitumor agents
#215Compounds useful as immunomodulators
#216Amido compounds as RORγt modulators and uses thereof
#217Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
#218Methods for the treatment of parkinson's disease psychosis using pimavanserin
#219FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE
#220Compositions and methods for combination ingredient delivery
#221Method of treating or preventing hyperlipidemia with caffeamide derivatives
#222Compositions of tolperisone
#223Use of Sigma-1 receptor agonist compounds
#224FLUORINATED ARYLALKYLAMINOCARBOXAMIDE DERIVATIVES
#225Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
#226Certain chemical entities, compositions, and methods
#227Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
#228Platform drug delivery system utilizing crystal engineering and theanine dissolution
#229TOPICAL COMPOSITIONS AND METHODS FOR SKIN LIGHTENING
#230Heterocyclic compounds
#231KDM1A inhibitors for the treatment of disease
#232INHIBITORS OF FAPP2 AND USES THEREOF
#233Bisarylsulfonamides useful in the treatment of inflammation and cancer
#234Methods of administering tolperisone for therapeutic purposes
#235GLP-1 receptor modulators
#236Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof
#2372-benzoylaminobenzamide derivatives as Bcl-3 inhibitors
#238HIGH PENETRATION PRODRUG COMPOSITIONS OF RETINOIDS AND RETINOID-RELATED COMPOUNDS
#239Sulfide alkyl compounds for HBV treatment
#240METALLO-B-LACTAMASE INHIBITORS
#241Bitopic muscarinic agonists and antagonists and methods of synthesis and use thereof
#242Cyclopropaneamine compound
#243Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors
#244Sulfamoylbenzamide derivatives as antiviral agents against HBV infection
#245COMPOSITION COMPRISING (S)-(-)-BENPROPERINE FOR PREVENTING OR TREATING CANCER
#246Synthesis of resorcylic acid lactones useful as therapeutic agents
#247Acrylamide compounds and use thereof for inhibiting apoptosis
#2482,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS
#249Estrogen receptor ligands and methods of use thereof
#250Treatment of neurological disorders
#251Prolonged-release diphenidol composition
#252Methods for the treatment of parkinson's disease psychosis using pimavanserin
#253Methods to treat, prevent, and improve skin conditions
#254Cyclic amines
#255ALTERNATIVE USES FOR HBV ASSEMBLY EFFECTORS
#256SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#257Piperidine derivatives and methods of treating hepatitis B infections
#258ALPROSTADIL FOR TREATMENT OF PREMATURE EJACULATION
#259Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
#260Compositions and methods for treating mammary tumors
#261Hepatitis B antiviral agents
#262TREATMENT OF AUTOPHAGY-BASED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTIC AND SCREENING ASSAYS AND KITS
#263Alpha hydroxy amides
#264Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#265Aryloxyurea compound and pest control agent
#266Small molecule inhibitors of viral protein interactions with human t-RNA
#267Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#268Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#269INHIBITORS OF HIPPO-YAP SIGNALING PATHWAY
#270Hepatitis B antiviral agents
#271Pharmaceutical composition of a papillomavirus inhibitor
#272Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors
#273Selective inhibitors of undifferentiated cells
#274Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereof
#275EP2 receptor agonists
#276Therapeutic Uses
#277Aryl derivatives and uses thereof
#278Estrogen antagonists as treatments for sclerosing disorders
#279Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
#280Alprostadil and lidocaine treatment of premature ejaculation
#281Alprostadil for treatment of premature ejaculation
#282Alprostadil and dyclonine for treatment of premature ejaculation
#283Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors
#284Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
#285Biguanide compositions and methods of treating metabolic disorders
#286BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE
#287MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF CANCER
#288Synergistic Combination Therapy
#289ANTI-ARENAVIRAL COMPOUNDS
#290Tropolone compounds for treating or preventing retroviral infection
#291Small molecule inhibitors of Mcl-1 and the uses of thereof
#292Methods for treating neural cell swelling
#293Compounds and methods of treating ocular disorders
#294Cyclopropaneamine compound
#295Sigma receptors ligands with anti-apoptotic and/or pro-apoptotic properties, over cellular mechanisms, exhibiting prototypical cytoprotective and also anti-cancer activity
#296Composite formulation comprising a tablet encapsulated in a hard capsule
#297SODIUM CHANNEL BLOCKERS REDUCE GLUCAGON SECRETION
#298Hepatitis B antiviral agents
#299Hepatitis B antiviral agents
#300Inhibitors of NCchannels for therapy